Project Grant R35GM163663
- Federal Grant Award Summary The University of California, San Francisco received a $501,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 5, 2025, with completion expected May 31, 2030. This five-year research initiative focuses on bridging the gap between predicted and experimentally determined atomic structures in structural biology. The project will develop...
- Federal Project Grant Award Summary The University of California, San Francisco received a $410,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through June 30, 2030. The award supports development of novel computational and analytical approaches to reconstruct heterogeneous infectious disease transmission dynamics from pathogen genomic sequence data. The...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $124,767 to The Regents of the University of California, San Francisco under the Biomedical Research and Research Training program (CFDA 93.859) for a two-year period commencing May 1, 2026 and concluding April 30, 2028. This award supports de novo protein design research focused on developing computationally designed proteins that bind small molecules and catalyze chemical...
- Federal Grant Award Summary The University of California, San Diego received a $638,334 Project Grant award dated September 8, 2025, through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) to develop innovative computational drug design technologies. The project, scheduled for completion by August 31, 2027, focuses on advancing understanding of protein-small molecule binding mechanisms by creating novel computational...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Regents of the University of California, San Francisco a $760,140 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) for the period July 1, 2025, through March 31, 2029. This award funds fundamental research investigating the cellular mechanisms of homologous chromosome pairing during meiosis. The primary deliverable is original scientific research examining how...
- Federal Grant Award Summary The University of California, Santa Barbara received a $391,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through April 30, 2031. This research award supports the development of advanced computational methodologies to study liquid-liquid phase separation (LLPS) of intrinsically disordered proteins (IDPs), which form biomolecular...
- Federal Project Grant Award Summary The University of California, San Francisco received a $445,049 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2031. The award supports research and development of membrane-inspired lipid nanoparticles (LNPs) designed to enable cell-type-specific delivery and expression of programmable RNA therapeutics. The...
- Federal Project Grant Award Summary The University of California, San Diego received a $327,019 Project Grant award dated July 25, 2025, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research through April 30, 2030, focusing on developing innovative biophysical and computational frameworks to understand how cells transform during embryogenesis and stem cell differentiation. The...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS), through its Biomedical Research and Research Training program (CFDA 93.859), awarded $150,104 to the University of California, San Francisco on August 8, 2026, for a Project Grant focused on de novo protein design. The research aims to engineer allosterically regulated proteins capable of intramolecular signal transduction—a fundamental process governing central metabolism, genetic regulatory networks, and...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, Berkeley $361,952 through the Biomedical Research and Research Training program (CFDA 93.859) to develop experimental and computational methods for systematic exploration of protein sequence-function relationships. Beginning September 1, 2025, and concluding June 30, 2030, this project delivers research focused on mapping mutational landscapes of biomedically...
The University of California, San Francisco received a $562,484 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) for the five-year period from May 1, 2026, through April 30, 2031. This award supports the development of next-generation visualization and analysis software tools designed to enable scientific discovery in biomedical research. The software will provide integrated visualizations and analyses of diverse biomolecular data, including atomic-resolution molecular coordinates, three-dimensional cryo-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET) density maps, and protein and nucleic acid sequences, annotations, and networks. The primary deliverables focus on interactive visualization and analysis tools for molecular structures, molecular assemblies, and sequence-structure relationships that directly address critical biomedical research needs, such as identifying molecular bases of disease, discovering drug development targets, designing therapeutics, and engineering proteins with novel functions. UCSF will leverage highly trained personnel with specialized expertise in software engineering, computer graphics, and data analysis to develop and disseminate these tools. The resulting software, including the widely-recognized ChimeraX platform, will be distributed freely as executable applications and source code through the project website and GitHub repository, supported by comprehensive documentation, tutorials, scientific publications, and web-accessible training videos to maximize scientific impact and accessibility across the biomedical research community.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $562.5k | 4/10/26 |